Fulviglen 250mg Injection, also known as Fulviglen 250Mg/5Ml Inj, is classified as an estrogen blocker primarily used in the treatment of breast cancer among postmenopausal women. Breast cancer is a type of cancer that arises when breast cells develop abnormally. The active ingredient in Fulviglen 250mg Injection is Fulvestrant, which effectively inhibits the actions of estrogen in the body. Estrogen is a female sex hormone that can potentially fuel the growth of cancer cells in women with breast cancer. By reducing estrogen levels, Fulviglen 250mg Injection aids in slowing down the growth of breast cancer tumors.

It is important to note that Fulviglen 250mg Injection should only be administered by a healthcare professional and not self-administered. The dosage and frequency of administration will be determined by your doctor based on your specific condition and symptoms. It is crucial to follow your doctor's instructions regarding the use of Fulviglen 250mg Injection.

Common side effects associated with Fulviglen 250mg Injection may include reactions at the injection site such as pain and inflammation, as well as symptoms like weakness, nausea, tiredness, headache, or joint and musculoskeletal pain. While most of these side effects are mild and transient, it is advisable to inform your doctor if they persist or worsen over time.

Before starting treatment with Fulviglen 250mg Injection, inform your healthcare provider if you have a history of kidney or liver disease, bleeding disorders, or if you are taking any other medications, as they may interact with Fulvestrant. It is particularly important to disclose if you are pregnant, planning to become pregnant, or breastfeeding, as Fulviglen 250mg Injection may have potential risks for unborn babies and nursing infants.

Additionally, individuals with known allergies to Fulvestrant or any other medications should notify their doctor before initiating treatment with Fulviglen 250mg Injection. It is advised to avoid alcohol consumption while undergoing Fulviglen 250mg Injection therapy, and if you experience tiredness or weakness after receiving the injection, refrain from driving or operating machinery until you feel fully alert.